Summary Three disease entities in COPD - aspergilloma - chronic aspergillosis - subacute invasive aspergillosis Controversial topic: no clear guidelines Studies warranted in - chronic aspergillosis: benefits of longterm triazole therapy - subacute IPA: pre-emptive approach based on galactomannan in BAL